Robert Kinders,
Sr. Principal Scientist and Head, Laboratory of Human Toxicology and Pharmacology
Robert Kinders is head of the Pharmacodynamics assay development (PADIS) laboratory at Frederick National Laboratory. The PADIS laboratory is charged with development and validation of assays to measure the effects, at the molecular level, of new, targeted anticancer agents in first-in-man clinical trials at the NCI Clinical Center. He received his Ph.D. in Biology at Kansas State University, and did post-doctoral studies at the University of Washington. His research has focused on cancer diagnostics and biomarkers. He has worked extensively in the U.S. Diagnostics Devices industry, including stints at Abbott Laboratories and C.R. Bard; and in pharmaceutical development at Abbott Laboratories and CuraGen.
|
.jpg)
|
|
